EUVIMEDEUVIMED entdecken
Crossref

Urinary Proteomics of Breast Cancer Patients from Gujarat for the Identification of Potential Biomarkers

Nandini Patel, Pooja Doshi, Anand Shah, Shashank Pandya, Vikas Patidar, Dhruvi Dixit, Ashish Patel, Snehal Bagatharia, Ishan Raval iD

Journal of Proteome Research · 2026

DOI: 10.1021/acs.jproteome.6c00497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Nandini Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gujarat Biotechnology Research Centre (GBRC) , 6th Floor, MS Building, GH Road, Sector-11, Gandhinagar, Gujarat382011, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Proteomics, Proteome. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Gujarat State Biotechnology Mission (GSBTM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer cases are rising annually across the globe, with treatment options limited and slim survival chances at the end stage of cancer; the need for an early diagnosis is crucial. The present study aims to explore a noninvasive method for breast cancer detection by analyzing urine collected from patients. In this preliminary study, LC-MS-based profiling has been employed on the proteins in urine samples from Gujarat-based breast cancer patients to find potential diagnostic biomarkers. Differential analysis using limma with Benjamini–Hochberg correction revealed 57 proteins that were upregulated in breast cancer, while 61 proteins were significantly downregulated (p-value ≤ 0.05, FC ≥ 2). ROC curve analysis yielded AUC values above 0.7 for candidate proteins, and functional enrichment analysis showed involvement of PI3K/AKT signaling, phosphoinositide metabolism, and RNA processing pathways. Based on FDR-controlled differential abundance, individual ROC performance, and biological relevance, TMC5, SFPQ, SLC27A5, PLCH2, SPG11, and INPP4B were prioritized as exploratory candidate proteins. These proteins demonstrated potential as noninvasive urinary biomarkers for detection of breast cancer, requiring targeted validation in an independent, clinically characterized cohort before investigating their diagnostic utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorProteomicsProteomeHumansFemaleROC CurveMiddle AgedIndiaAdult

Stichwörter der Autor:innen

Gujarat populationbiomarker discoverybreast cancerurinary proteomics

Substanzen

Biomarkers, TumorProteome

Autor:innen und Institutionen

  • Gujarat Biotechnology Research Centre (GBRC) , 6th Floor, MS Building, GH Road, Sector-11, Gandhinagar, Gujarat382011, India.
  • The Gujarat Cancer & Research Institute (GCRI), Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat380016, India.

ORCID-Profile: Ishan Raval

Förderung

  • Gujarat State Biotechnology Mission (GSBTM)

Zitieren

APA

Patel, N., Doshi, P., Shah, A., Pandya, S., Patidar, V., Dixit, D., Patel, A., Bagatharia, S., & Raval, I. (2026). Urinary Proteomics of Breast Cancer Patients from Gujarat for the Identification of Potential Biomarkers. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6c00497

Vancouver

Patel N, Doshi P, Shah A, Pandya S, Patidar V, Dixit D, et al. Urinary Proteomics of Breast Cancer Patients from Gujarat for the Identification of Potential Biomarkers. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.6c00497

BibTeX
@article{Patel2026,
  author = {Patel, Nandini and Doshi, Pooja and Shah, Anand and Pandya, Shashank and Patidar, Vikas and Dixit, Dhruvi and Patel, Ashish and Bagatharia, Snehal and Raval, Ishan},
  title = {Urinary Proteomics of Breast Cancer Patients from Gujarat for the Identification of Potential Biomarkers},
  journal = {Journal of Proteome Research},
  year = {2026},
  doi = {10.1021/acs.jproteome.6c00497}
}
Kostenlos starten →